Shares of HealthEquity (HQY) surged 5.66% in Wednesday's trading session, following the company's impressive second-quarter fiscal 2026 results and upward revision of full-year guidance. The leading provider of Health Savings Account (HSA) custodial services in the United States demonstrated robust financial performance, surpassing analyst expectations and showcasing significant year-over-year growth.

HealthEquity reported a 9% year-over-year increase in revenue, reaching $325.8 million for Q2, beating the analyst estimate of $320.82 million. The company's bottom line saw an even more substantial improvement, with net income soaring 67% to $59.9 million. Adjusted earnings per share came in at $1.08, significantly outperforming the Street estimate of 92 cents and marking a 26% increase from the previous year.

Following these strong results, HealthEquity's management raised its full-year guidance for fiscal 2026 across all major metrics. The company now projects revenue between $1.290 billion and $1.310 billion, with adjusted EBITDA expected to range from $540 million to $560 million. This optimistic outlook, coupled with the company's solid execution in expanding its HSA business and improving operational efficiency, has garnered positive attention from Wall Street. Several analysts, including those from JPMorgan and BTIG, have maintained their bullish stance on the stock, with some raising their price targets in response to the results. The surge in stock price reflects investors' confidence in HealthEquity's growth trajectory and its positioning in the expanding HSA market.